MAGNETOM Combi Suite Neurosurgery
Improving the management of brain tumor patients.
MAGNETOM Combi Suite Neurosurgery combines premium MRI technology with state-of-the art OR solutions. Resulting in highly detailed image quality, safe, efficient patient set-up and -transport, as well as cost-effective and flexible solutions for siting and OR tables.
MRI guidance in neurosurgery can significantly improve the management of brain tumor patients:
- Revealing residual tumor in 65% of patients in an intraoperative setting.1
- Maximizing the extent of resection,improving patient survival by up to 55%.1
- Helping to achieve five times more total resections, compared to white-light surgery.2
Kuhnt, D. et al. (2011). Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiform with high-field intraoperative MRI guidance. Neuro-Oncology, 13 (12), 1339-1348.
Roder, C. et al. (2013). Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: High-field iMRI versus conventional and 5-ALAassisted surgery. EUR J Surg Oncol, in press.